Search Results 241-250 of 16042 for GLP-1 agonist
About this study. This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called ...
Receiving a glucagon-like peptide 1 (GLP-1) receptor agonist, a dipeptidyl peptidase 4 (DPP-4) inhibitor, a sodium–glucose cotransporter 2 (SGLT2) and/or ...
... 1 and Type 2 diabetes and gastroparesis. Participation eligibility ... Currently taking GLP-1 agonists, SGLT2 inhibitors or pramlintide; Allergic or ...
In most cases, sleep medicines should only be used for short periods of time, such as 1 or 2 days, and for no longer than 1 or 2 weeks. This medicine is ...
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Abemaciclib; Abiraterone Acetate ...
The best one for you depends on many things, including your overall health. For example, an ACE inhibitor may help if you have chronic kidney disease ...
Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec 05, 2025. See more discussions. Related. Associated Procedures. Heart valve ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...
Other genes can increase the risk of getting certain diseases, including AATD. One gene tells the liver to make alpha-1-antitrypsin (AAT or A1AT) protein. This ...
A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls · Overview · Participation eligibility · Participating Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.